» Articles » PMID: 22675383

Effect of Cymbopogon Citratus and Citral on Vascular Smooth Muscle of the Isolated Thoracic Rat Aorta

Overview
Date 2012 Jun 8
PMID 22675383
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Cymbopogon citratus has been shown to have antioxidant, antimicrobial, antispasmodic and chemo-protective properties. Citral, is the major constituent of C. citratus. This study investigated the effects of methanolic extracts of leaves (LE), stems (SE), and roots (RE) of C. citratus and citral on vascular smooth muscle and explored their possible mechanisms of action. The experiment was conducted using isolated tissue preparations, where citral, LE, SE, and RE were added separately into a tissue bath that contained aortic rings, which were pre-contracted with phenylephrine (PE). Citral, LE, and RE exhibited a dose-dependent relaxant effect on the PE-induced contractions. Citral appeared to partially act via NO as its vasorelaxant effect was attenuated by L-NAME. However, the effect of LE may involve prostacyclin as indomethacin reversed the relaxant effect of LE on the PE-induced contraction. Furthermore, citral, LE, and RE abolished the restoration of PE-induced contraction caused by the addition of increasing doses of calcium in both endothelium intact and denuded rings. These findings suggest that the relaxation effect of citral, LE, and RE is endothelium-independent and may be mainly by affecting the intracellular concentration of calcium. Citral may partially act through the NO pathway while a vasodilator prostaglandin may mediate the effect of LE.

Citing Articles

Bioactive molecules from terrestrial and seafood resources in hypertension treatment: focus on molecular mechanisms and targeted therapies.

Islam M, Dhar P, Akash S, Syed S, Gupta J, Gandla K Nat Prod Bioprospect. 2023; 13(1):45.

PMID: 37902881 PMC: 10616036. DOI: 10.1007/s13659-023-00411-1.


Exploring the Anti-Hypertensive Potential of Lemongrass-A Comprehensive Review.

Silva H, Barbara R Biology (Basel). 2022; 11(10).

PMID: 36290288 PMC: 9598547. DOI: 10.3390/biology11101382.


Melissa officinalis L. Supplementation Provides Cardioprotection in a Rat Model of Experimental Autoimmune Myocarditis.

Draginic N, Jakovljevic V, Jeremic J, Srejovic I, Andjic M, Rankovic M Oxid Med Cell Longev. 2022; 2022:1344946.

PMID: 35265259 PMC: 8901324. DOI: 10.1155/2022/1344946.


Medicinal Plants in the Treatment of Hypertension: A Review.

Kamyab R, Namdar H, Torbati M, Ghojazadeh M, Araj-Khodaei M, Bagher Fazljou S Adv Pharm Bull. 2021; 11(4):601-617.

PMID: 34888207 PMC: 8642800. DOI: 10.34172/apb.2021.090.


L. as a Nutritional Strategy for Cardioprotection.

Draginic N, Jakovljevic V, Andjic M, Jeremic J, Srejovic I, Rankovic M Front Physiol. 2021; 12:661778.

PMID: 33967832 PMC: 8100328. DOI: 10.3389/fphys.2021.661778.


References
1.
Carlini E, Contar J de D, Frochtengarten M, Bueno O . Pharmacology of lemongrass (Cymbopogon citratus Stapf). I. Effects of teas prepared from the leaves on laboratory animals. J Ethnopharmacol. 1986; 17(1):37-64. DOI: 10.1016/0378-8741(86)90072-3. View

2.
Paoletti R, Govoni S . Classification of calcium antagonists: proposal of the WHO Committee. Pharmacol Res Commun. 1987; 19(3):195-208. DOI: 10.1016/0031-6989(87)90063-4. View

3.
Moncada S . Prostaglandin endoperoxides and thromboxanes: formation and effects. Naunyn Schmiedebergs Arch Pharmacol. 1977; 297 Suppl 1:S81-4. DOI: 10.1007/BF00587788. View

4.
Rosenfeldt F, He G, Buxton B, Angus J . Pharmacology of coronary artery bypass grafts. Ann Thorac Surg. 1999; 67(3):878-88. DOI: 10.1016/s0003-4975(98)01299-5. View

5.
Pinto Y, Paul M, Ganten D . Lessons from rat models of hypertension: from Goldblatt to genetic engineering. Cardiovasc Res. 1998; 39(1):77-88. DOI: 10.1016/s0008-6363(98)00077-7. View